Sangamo Biosciences, Inc. (SGMO) Reports In-Line Q4 EPS Loss of $0.12
Tweet
Share
E-mailGet Alerts SGMO Hot Sheet
Price: $0.18 --0%
Revenue Growth %: -19.8%
Financial Fact:
Loss from operations: -19.21M
Today's EPS Names:
PLCE, COE, JVA, More
Revenue Growth %: -19.8%
Financial Fact:
Loss from operations: -19.21M
Today's EPS Names:
PLCE, COE, JVA, More
Join SI Premium – FREE
Sangamo Biosciences, Inc. (NASDAQ: SGMO) reported Q4 EPS of ($0.12), in-line with the analyst estimate of ($0.12). Revenue for the quarter came in at $4.7 million versus the consensus estimate of $3.41 million.
Sangamo Biosciences, Inc. sees FY2012 revenue of $14-$18 million, versus the consensus of $16.23 million.
For earnings history and earnings-related data on Sangamo Biosciences, Inc. (SGMO) click here.
Sangamo Biosciences, Inc. sees FY2012 revenue of $14-$18 million, versus the consensus of $16.23 million.
For earnings history and earnings-related data on Sangamo Biosciences, Inc. (SGMO) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Nvidia pitches Vera CPU to Chinese clients with August delivery target
- Dollarama Inc. (DOL:CN) (DLMAF) PT Raised to Cdn$221 at BMO Capital
- Vera Bradley (VRA) Misses Q1 EPS by 26c ; Offers Guidance
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
